Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Waldenström's Macroglobulinemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04263480
What this trial is testing

Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Christian Buske 99
Not applicableStudy completedNCT02640287
What this trial is testing

Expression of Ku70/XRCC6 in Waldenström's Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia
Central Hospital, Nancy, France 55
Testing effectiveness (Phase 2)Study completedNCT03630042
What this trial is testing

Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia

Who this might be right for
Waldenstrom Macroglobulinemia
University College, London 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05952037
What this trial is testing

Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia

Who this might be right for
Waldenstrom MacroglobulinemiaWaldenstrom's Macroglobulinemia RecurrentWaldenstrom's Macroglobulinemia Refractory
BeOne Medicines 114
Early research (Phase 1)WithdrawnNCT02238522
What this trial is testing

Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML

Who this might be right for
Lymphoproliferative MalignanciesAcute Myeloid Leukemia
Zenith Epigenetics
Testing effectiveness (Phase 2)UnknownNCT05979948
What this trial is testing

Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
Shanghai Changzheng Hospital 60
Post-approval studies (Phase 4)Study completedNCT04042376
What this trial is testing

Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM)

Who this might be right for
Waldenstrom Macroglobulinemia
Janssen Research & Development, LLC 17
Testing effectiveness (Phase 2)Study completedNCT00398710
What this trial is testing

A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
AEterna Zentaris 37
Testing effectiveness (Phase 2)Study completedNCT01813227
What this trial is testing

A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531

Who this might be right for
Waldenstrom Macroglobulinemia
Hackensack Meridian Health 7
Testing effectiveness (Phase 2)Ended earlyNCT03269552
What this trial is testing

Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma

Who this might be right for
Marginal Zone LymphomaRecurrent Marginal Zone LymphomaRecurrent Waldenstrom Macroglobulinemia+3 more
University of Washington 4
Testing effectiveness (Phase 2)Study completedNCT03332173
What this trial is testing

Study of BTK Inhibitor BGB-3111 in Chinese Subjects With Relapsed/Refractory Waldenström's Macroglobulinemia (WM)

Who this might be right for
Waldenström's Macroglobulinemia (WM)
BeiGene 44
Testing effectiveness (Phase 2)Looking for participantsNCT07231952
What this trial is testing

Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

Who this might be right for
Waldenstrom MacroglobulinemiaLymphoplasmacytic Lymphoma
Memorial Sloan Kettering Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00608374
What this trial is testing

Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma

Who this might be right for
Lymphoma
Taunton and Somerset Hospital 400
Testing effectiveness (Phase 2)UnknownNCT03697356
What this trial is testing

R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
Kosin University Gospel Hospital 54
Testing effectiveness (Phase 2)Study completedNCT00777738
What this trial is testing

Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Assistance Publique - Hôpitaux de Paris 34
Large-scale testing (Phase 3)Study completedNCT01788020
What this trial is testing

Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
University of Ulm 202
Not applicableLooking for participantsNCT05326308
What this trial is testing

Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma

Who this might be right for
Waldenström's MacroglobulinemiaChronic Lymphocytic LeukemiaMarginal Zone Lymphoma+1 more
iOMEDICO AG 845